Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (37)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Papanikolaou, A.
Right arrow Articles by Rosenberg, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Papanikolaou, A.
Right arrow Articles by Rosenberg, D. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 21, No. 8, 1567-1572, August 2000
© 2000 Oxford University Press


Carcinogenesis

Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis

Alexandros Papanikolaou2, Qian-Shu Wang, Demetrios Papanikolaou, Herbert E. Whiteley1 and Daniel W. Rosenberg2,3

Department of Pharmaceutical Sciences and
1 Department of Pathobiology, University of Connecticut, Storrs, CT 06269–2092, USA

Aberrant crypt foci (ACF), putative preneoplastic lesions, are early morphological changes induced by the colon carcinogen azoxymethane (AOM). Although inbred mice differ markedly in their susceptibility to AOM carcinogenesis, we have previously shown that ACF develop in both resistant and sensitive mouse strains after AOM treatment. The purpose of this study was to examine the sequential development and identify the morphological characteristics of ACF induced by AOM in the distal colon of sensitive and resistant mice. A/J (highly susceptible), SWR/J (relatively susceptible) and AKR/J (resistant) mice were treated with 10 mg/kg AOM or saline i.p. once a week for 6 weeks and were killed at 1, 2, 4, 6, 9 and 24 weeks after the last injection. The distal colons were stained with methylene blue and the numbers of ACF and tumors determined. Tumors were present as early as 4 weeks after AOM exposure in SWR/J and A/J mice and increased in frequency throughout the study in both strains. No tumors developed in the AKR/J mice. ACF, however, formed in all strains of mice. The greatest difference between susceptible and resistant strains was in the number of large ACF that developed at later time points. Furthermore, morphometric analysis revealed that A/J mice had the highest percentage of dysplastic ACF, followed by SWR/J mice. These data indicate that the difference in cancer risk from AOM may be due to the lack of progression of smaller ACF in the resistant mice and to the development of dysplasia in a higher percentage of ACF from susceptible strains.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
D. W. Rosenberg, C. Giardina, and T. Tanaka
Mouse models for the study of colon carcinogenesis
Carcinogenesis, February 1, 2009; 30(2): 183 - 196.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
A. P. Femia, A. Giannini, M. Fazi, E. Tarquini, M. Salvadori, L. Roncucci, F. Tonelli, P. Dolara, and G. Caderni
Identification of Mucin Depleted Foci in the Human Colon
Cancer Prevention Research, December 1, 2008; 1(7): 562 - 567.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. B. Halberg, M. C. Larsen, T. L. Elmergreen, A. Y. Ko, A. A. Irving, L. Clipson, and C. R. Jefcoate
Cyp1b1 Exerts Opposing Effects on Intestinal Tumorigenesis via Exogenous and Endogenous Substrates
Cancer Res., September 15, 2008; 68(18): 7394 - 7402.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. W. Schweinfest, D. D. Spyropoulos, K. W. Henderson, J.-H. Kim, J. M. Chapman, S. Barone, R. T. Worrell, Z. Wang, and M. Soleimani
slc26a3 (dra)-deficient Mice Display Chloride-losing Diarrhea, Enhanced Colonic Proliferation, and Distinct Up-regulation of Ion Transporters in the Colon
J. Biol. Chem., December 8, 2006; 281(49): 37962 - 37971.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Z. Derdak, P. Fulop, E. Sabo, R. Tavares, E. P. Berthiaume, M. B. Resnick, G. Paragh, J. R. Wands, and G. Baffy
Enhanced colon tumor induction in uncoupling protein-2 deficient mice is associated with NF-{kappa}B activation and oxidative stress
Carcinogenesis, May 1, 2006; 27(5): 956 - 961.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. Suzuki, H. Kohno, S. Sugie, H. Nakagama, and T. Tanaka
Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice
Carcinogenesis, January 1, 2006; 27(1): 162 - 169.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. N.M. Ilsley, M. Nakanishi, C. Flynn, G. S. Belinsky, S. De Guise, J. N. Adib, R. T. Dobrowsky, J. V. Bonventre, and D. W. Rosenberg
Cytoplasmic Phospholipase A2 Deletion Enhances Colon Tumorigenesis
Cancer Res., April 1, 2005; 65(7): 2636 - 2643.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. W.L. Ma, R. H. Finnell, L. A. Davidson, E. S. Callaway, O. Spiegelstein, J. A. Piedrahita, J. M. Salbaum, C. Kappen, B. R. Weeks, J. James, et al.
Folate Transport Gene Inactivation in Mice Increases Sensitivity to Colon Carcinogenesis
Cancer Res., February 1, 2005; 65(3): 887 - 897.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. E. Paulsen, E. M. Loberg, H. B. Olstorn, H. Knutsen, I.-L. Steffensen, and J. Alexander
Flat Dysplastic Aberrant Crypt Foci Are Related to Tumorigenesis in the Colon of Azoxymethane-Treated Rat
Cancer Res., January 1, 2005; 65(1): 121 - 129.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. R. Nambiar, M. Nakanishi, R. Gupta, E. Cheung, A. Firouzi, X.-J. Ma, C. Flynn, M. Dong, K. Guda, J. Levine, et al.
Genetic signatures of High- and Low-Risk Aberrant Crypt Foci in a Mouse Model of Sporadic Colon Cancer
Cancer Res., September 15, 2004; 64(18): 6394 - 6401.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Caderni, A. P. Femia, A. Giannini, A. Favuzza, C. Luceri, M. Salvadori, and P. Dolara
Identification of Mucin-depleted Foci in the Unsectioned Colon of Azoxymethane-treated Rats: Correlation with Carcinogenesis
Cancer Res., May 15, 2003; 63(10): 2388 - 2392.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y. Hirose, T. Kuno, Y. Yamada, K. Sakata, M. Katayama, K. Yoshida, Z. Qiao, K. Hata, N. Yoshimi, and H. Mori
Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis
Carcinogenesis, January 1, 2003; 24(1): 107 - 111.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Erik Paulsen, I.-L. Steffensen, E. M. Loberg, T. Husoy, E. Namork, and J. Alexander
Qualitative and Quantitative Relationship between Dysplastic Aberrant Crypt Foci and Tumorigenesis in the Min/+ Mouse Colon
Cancer Res., July 1, 2001; 61(13): 5010 - 5015.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.